InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Gupta Suneel, Directeur. Director active across 1 company, notably Protagonist Therapeutics, Inc. Aggregated, 4 filings have been recorded. History available since 15 February 2022. The latest transaction was filed on 26 April 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
40,000 shares@ US$7.380.0051% mcap95.2% of flowCommon StockSEC:0001104659-22-050560:0
649 shares@ US$24.280.0003% mcap4.8% of flowCommon StockSEC:0001104659-22-029522:0
12,500 shares0Common StockSEC:0001104659-22-024838:0
12,500 shares0Common StockSEC:0001104659-22-024838
4 of 4 declarations
About Gupta Suneel
Suneel Gupta serves as the Chief Development Officer at Protagonist Therapeutics, Inc. In this role, he is responsible for leading strategic development and innovation initiatives within the company. His expertise in the biotechnology field contributes to the advancement of research and development projects.
